NADPH oxidase 4 contributes to oxidative stress in a mouse model of myocardial infarction

Q Huang1, Y Chen

  • 1Department of Geratology, Jiangnan University Medical Center, JUMC, Wuxi, Jiangsu Province, China. yanping03060130@sina.com.

Insights

Targeting Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) with siRNA in the heart reduces oxidative stress and improves cardiac function following myocardial infarction (MI). This suggests NOX4 inhibition as a potential therapy for heart dysfunction.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Oxidative Stress Research

Background:

  • Oxidative stress is a key factor in myocardial infarction (MI) progression and severity.
  • Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) is a primary source of reactive oxygen species (ROS) in the cardiovascular system.

Purpose of the Study:

  • To investigate the pathological role of NOX4 in myocardial infarction (MI).
  • To evaluate the therapeutic potential of inhibiting NOX4 in MI-induced cardiac dysfunction.

Main Methods:

  • Established a myocardial infarction (MI) mouse model using coronary artery ligation.
  • Utilized intramyocardial injection of small interfering RNA (siRNA) for specific cardiac NOX4 knockdown.
  • Quantified NOX4 expression, ROS production, and oxidative stress markers via qRT-PCR, Western blot, and ELISA.
  • Assessed cardiac function using echocardiography.

Main Results:

  • NOX4 expression was upregulated in MI mouse hearts and correlated positively with oxidative stress indicators.
  • Cardiac NOX4 knockdown significantly reduced ROS production and oxidative stress in the left ventricle.
  • NOX4 inhibition led to a significant improvement in cardiac function in MI mice.

Conclusions:

  • Selective NOX4 knockdown in the heart attenuates MI-induced oxidative stress and improves cardiac function.
  • The NOX4/ROS axis in the heart represents a promising therapeutic target for MI-induced cardiac dysfunction.
  • siRNA-mediated inhibition of NOX4 offers a potential treatment strategy for myocardial infarction.

Related Concept Videos